Baker Mark Robert 4
4 · PROGENICS PHARMACEUTICALS INC · Filed Feb 28, 2013
Insider Transaction Report
Form 4
Baker Mark Robert
General Counsel
Transactions
- Purchase
Common Stock
2013-02-27$2.71/sh+500$1,355→ 159,729 total - Purchase
Common Stock
2013-02-27$2.72/sh+535$1,455→ 160,264 total - Purchase
Common Stock
2013-02-27$2.75/sh+227$624→ 160,491 total
Footnotes (1)
- [F1]Open market purchase pursuant to a 10b5-1 trading plan adopted by the Reporting Person in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.